Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Angiomyolipomas”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Study completedNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2
Not applicableUnknownNCT02887781
What this trial is testing

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

Who this might be right for
Tuberous Sclerosis Complex
University Hospital, Brest 150
Not applicableActive Not RecruitingNCT06126159
What this trial is testing

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Who this might be right for
Kidney Neoplasms
Chang Gung Memorial Hospital 44
Not applicableLooking for participantsNCT05785052
What this trial is testing

Biomarkers of Renal Cancer

Who this might be right for
Renal Cell CarcinomaTumor, SolidOncocytoma+1 more
Biorek S.R.L. 1,000
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Testing effectiveness (Phase 2)Study completedNCT00126672
What this trial is testing

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Who this might be right for
Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more
Dana-Farber Cancer Institute 36
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400